These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 25441634)

  • 1. Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy.
    Focke-Tejkl M; Weber M; Niespodziana K; Neubauer A; Huber H; Henning R; Stegfellner G; Maderegger B; Hauer M; Stolz F; Niederberger V; Marth K; Eckl-Dorna J; Weiss R; Thalhamer J; Blatt K; Valent P; Valenta R
    J Allergy Clin Immunol; 2015 May; 135(5):1207-7.e1-11. PubMed ID: 25441634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.
    Marth K; Breyer I; Focke-Tejkl M; Blatt K; Shamji MH; Layhadi J; Gieras A; Swoboda I; Zafred D; Keller W; Valent P; Durham SR; Valenta R
    J Immunol; 2013 Apr; 190(7):3068-78. PubMed ID: 23440415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy.
    Zieglmayer P; Focke-Tejkl M; Schmutz R; Lemell P; Zieglmayer R; Weber M; Kiss R; Blatt K; Valent P; Stolz F; Huber H; Neubauer A; Knoll A; Horak F; Henning R; Valenta R
    EBioMedicine; 2016 Sep; 11():43-57. PubMed ID: 27650868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular evolution of hypoallergenic hybrid proteins for vaccination against grass pollen allergy.
    Linhart B; Focke-Tejkl M; Weber M; Narayanan M; Neubauer A; Mayrhofer H; Blatt K; Lupinek C; Valent P; Valenta R
    J Immunol; 2015 Apr; 194(8):4008-18. PubMed ID: 25786690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
    Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R
    Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG
    Eckl-Dorna J; Weber M; Stanek V; Linhart B; Ristl R; Waltl EE; Villazala-Merino S; Hummel A; Focke-Tejkl M; Froeschel R; Neubauer A; Henning R; Perkmann T; Valenta R; Niederberger V
    EBioMedicine; 2019 Dec; 50():421-432. PubMed ID: 31786130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A hypoallergenic vaccine obtained by tail-to-head restructuring of timothy grass pollen profilin, Phl p 12, for the treatment of cross-sensitization to profilin.
    Westritschnig K; Linhart B; Focke-Tejkl M; Pavkov T; Keller W; Ball T; Mari A; Hartl A; Stöcklinger A; Scheiblhofer S; Thalhamer J; Ferreira F; Vieths S; Vogel L; Böhm A; Valent P; Valenta R
    J Immunol; 2007 Dec; 179(11):7624-34. PubMed ID: 18025208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection.
    Cornelius C; Schöneweis K; Georgi F; Weber M; Niederberger V; Zieglmayer P; Niespodziana K; Trauner M; Hofer H; Urban S; Valenta R
    EBioMedicine; 2016 Sep; 11():58-67. PubMed ID: 27568223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen Phl p 1.
    Edlmayr J; Niespodziana K; Linhart B; Focke-Tejkl M; Westritschnig K; Scheiblhofer S; Stoecklinger A; Kneidinger M; Valent P; Campana R; Thalhamer J; Popow-Kraupp T; Valenta R
    J Immunol; 2009 May; 182(10):6298-306. PubMed ID: 19414783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32.
    Niederberger V; Neubauer A; Gevaert P; Zidarn M; Worm M; Aberer W; Malling HJ; Pfaar O; Klimek L; Pfützner W; Ring J; Darsow U; Novak N; Gerth van Wijk R; Eckl-Dorna J; Focke-Tejkl M; Weber M; Müller HH; Klinger J; Stolz F; Breit N; Henning R; Valenta R
    J Allergy Clin Immunol; 2018 Aug; 142(2):497-509.e9. PubMed ID: 29361332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hypoallergenic cat vaccine based on Fel d 1-derived peptides fused to hepatitis B PreS.
    Niespodziana K; Focke-Tejkl M; Linhart B; Civaj V; Blatt K; Valent P; van Hage M; Grönlund H; Valenta R
    J Allergy Clin Immunol; 2011 Jun; 127(6):1562-70.e6. PubMed ID: 21411130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination.
    Focke M; Mahler V; Ball T; Sperr WR; Majlesi Y; Valent P; Kraft D; Valenta R
    FASEB J; 2001 Sep; 15(11):2042-4. PubMed ID: 11511525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant PreS-fusion protein vaccine for birch pollen and apple allergy.
    Khaitov M; Shilovskiy I; Valenta R; Weber M; Korneev A; Tulaeva I; Gattinger P; van Hage M; Hofer G; Konradsen JR; Keller W; Akinfenwa O; Poroshina A; Ilina N; Fedenko E; Elisyutina O; Litovkina A; Smolnikov E; Nikonova A; Rybalkin S; Aldobaev V; Smirnov V; Shershakova N; Petukhova O; Kudlay D; Shatilov A; Timofeeva A; Campana R; Udin S; Skvortsova V
    Allergy; 2024 Apr; 79(4):1001-1017. PubMed ID: 37855043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic engineering of the major timothy grass pollen allergen, Phl p 6, to reduce allergenic activity and preserve immunogenicity.
    Vrtala S; Focke M; Kopec J; Verdino P; Hartl A; Sperr WR; Fedorov AA; Ball T; Almo S; Valent P; Thalhamer J; Keller W; Valenta R
    J Immunol; 2007 Aug; 179(3):1730-9. PubMed ID: 17641039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of allergenic activity of the major grass pollen allergen Phl p 2 by reassembly as a mosaic protein.
    Mothes-Luksch N; Stumvoll S; Linhart B; Focke M; Krauth MT; Hauswirth A; Valent P; Verdino P; Pavkov T; Keller W; Grote M; Valenta R
    J Immunol; 2008 Oct; 181(7):4864-73. PubMed ID: 18802090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination vaccines for the treatment of grass pollen allergy consisting of genetically engineered hybrid molecules with increased immunogenicity.
    Linhart B; Jahn-Schmid B; Verdino P; Keller W; Ebner C; Kraft D; Valenta R
    FASEB J; 2002 Aug; 16(10):1301-3. PubMed ID: 12154002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: importance for allergenic activity.
    Flicker S; Steinberger P; Ball T; Krauth MT; Verdino P; Valent P; Almo S; Valenta R
    J Allergy Clin Immunol; 2006 Jun; 117(6):1336-43. PubMed ID: 16750995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A B Cell Epitope Peptide Derived from the Major Grass Pollen Allergen Phl p 1 Boosts Allergen-Specific Secondary Antibody Responses without Allergen-Specific T Cell Help.
    Narayanan M; Freidl R; Focke-Tejkl M; Baranyi U; Wekerle T; Valenta R; Linhart B
    J Immunol; 2017 Feb; 198(4):1685-1695. PubMed ID: 28093528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
    Linhart B; Mothes-Luksch N; Vrtala S; Kneidinger M; Valent P; Valenta R
    Biol Chem; 2008 Jul; 389(7):925-33. PubMed ID: 18627317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of an allergy vaccine by disruption of the three-dimensional structure of the cross-reactive calcium-binding allergen, Phl p 7.
    Westritschnig K; Focke M; Verdino P; Goessler W; Keller W; Twardosz A; Mari A; Horak F; Wiedermann U; Hartl A; Thalhamer J; Sperr WR; Valent P; Valenta R
    J Immunol; 2004 May; 172(9):5684-92. PubMed ID: 15100313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.